Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders

NCT01850355 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01850355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01850355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2013
Completion date
December 31, 2024
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, autism spectrum disorders